About Prosensa
Mission Statement
"We aim to make a difference by providing RNA-based therapeutics to patients with genetic diseases for whom currently no treatment exists."
Company Profile
Prosensa is a biopharmaceutical company focused on the discovery, development and commercialization of RNA modulating therapeutics. The company targets genetic disorders with a large unmet medical need, with a primary focus on neuromuscular disorders.
Strategy
Prosensa was established to develop novel treatments for life-threatening diseases based on its RNA modulation platform. Prosensa intends to discover, develop and commercialize these products and to create a specialized orphan drug franchise.
Strategic Partners
Prosensa closely collaborates with a group of strong key academic and industrial / corporate partners in order to achieve its objective of bringing innovative treatments to patients as quickly as possible.
Contact Prosensa
Phone: +31 (0) 71 33 22 100
Monday - Friday from 8.30 till 17.00